{
    "2021-10-07": [
        [
            {
                "time": "",
                "original_text": "【浙商医药┃孙建】周报：国内细胞治疗行业是好赛道么？",
                "features": {
                    "keywords": [
                        "细胞治疗",
                        "行业",
                        "赛道"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "复星医药梳理体外诊断业务 拟近16亿元出售两项目资产 资产异常",
                "features": {
                    "keywords": [
                        "复星医药",
                        "体外诊断",
                        "资产出售",
                        "异常"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "复星医药：拟以人民币约15.96亿元的对价向买方转让所持有的亚能生物29.02%的股权以及向买方与亚能生物共同指定的主体转让所持有的金石医检所100%的股权",
                "features": {
                    "keywords": [
                        "复星医药",
                        "股权转让",
                        "亚能生物",
                        "金石医检所"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "【异动股】复星医药(02196.HK)涨4.61%",
                "features": {
                    "keywords": [
                        "复星医药",
                        "股价上涨",
                        "异动股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}